Illumina (ILMN) Competitors $87.53 -0.49 (-0.56%) Closing price 04:00 PM EasternExtended Trading$87.90 +0.38 (+0.43%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Does the media refer more to ILMN or A? In the previous week, Agilent Technologies had 20 more articles in the media than Illumina. MarketBeat recorded 44 mentions for Agilent Technologies and 24 mentions for Illumina. Illumina's average media sentiment score of 1.45 beat Agilent Technologies' score of 0.96 indicating that Illumina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 16 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 28 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Is ILMN or A more profitable? Agilent Technologies has a net margin of 19.27% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.56% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Illumina-27.95% 13.37% 5.49% Agilent Technologies 19.27%25.56%13.47% Do institutionals & insiders have more ownership in ILMN or A? 89.4% of Illumina shares are owned by institutional investors. 0.2% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in ILMN or A? Illumina received 247 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.08% of users gave Agilent Technologies an outperform vote while only 65.33% of users gave Illumina an outperform vote. CompanyUnderperformOutperformIlluminaOutperform Votes111265.33% Underperform Votes59034.67% Agilent TechnologiesOutperform Votes86571.08% Underperform Votes35228.92% Which has more volatility & risk, ILMN or A? Illumina has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Do analysts rate ILMN or A? Illumina currently has a consensus price target of $140.90, indicating a potential upside of 60.97%. Agilent Technologies has a consensus price target of $146.15, indicating a potential upside of 21.44%. Given Illumina's higher possible upside, research analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 1 Sell rating(s) 10 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.48Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has higher valuation & earnings, ILMN or A? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.37B3.17-$1.22B-$7.68-11.40Agilent Technologies$6.51B5.27$1.29B$4.3527.67 SummaryAgilent Technologies beats Illumina on 11 of the 19 factors compared between the two stocks. Remove Ads Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.86B$4.64B$5.68B$8.32BDividend YieldN/A0.51%4.55%4.02%P/E Ratio-11.4026.5724.5819.25Price / Sales3.174.48395.7394.10Price / Cash20.7236.3438.1634.64Price / Book5.841.777.064.46Net Income-$1.22B-$83.57M$3.20B$247.07M7 Day Performance2.78%-2.23%1.49%3.06%1 Month Performance-8.56%-12.10%5.87%-2.85%1 Year Performance-34.71%-32.01%14.97%4.64% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.6581 of 5 stars$87.53-0.6%$140.90+61.0%-35.9%$13.86B$4.37B-11.409,030Positive NewsAAgilent Technologies4.0309 of 5 stars$121.59+0.7%$146.15+20.2%-17.3%$34.66B$6.51B27.9517,900Analyst RevisionMTDMettler-Toledo International3.804 of 5 stars$1,211.94+1.1%$1,380.50+13.9%-8.7%$25.26B$3.87B29.9018,000Positive NewsWATWaters3.5672 of 5 stars$370.75+1.4%$391.07+5.5%+7.4%$22.04B$2.96B34.637,900TECHBio-Techne4.8952 of 5 stars$60.73+0.2%$81.25+33.8%-14.6%$9.60B$1.20B61.343,100Positive NewsCRLCharles River Laboratories International4.4505 of 5 stars$166.87-0.2%$189.77+13.7%-38.6%$8.53B$4.05B1,112.4721,800BIOBio-Rad Laboratories4.5061 of 5 stars$255.68-0.4%$395.20+54.6%-26.6%$7.16B$2.57B-3.937,700Positive NewsBRKRBruker4.75 of 5 stars$44.47+0.0%$70.50+58.5%-52.6%$6.74B$3.37B58.448,520PACBPacific Biosciences of California2.391 of 5 stars$1.32+1.2%$2.79+112.3%-63.9%$391.68M$154.01M-0.80730Analyst ForecastHBIOHarvard Bioscience3.9062 of 5 stars$0.60-5.0%$4.50+645.0%-85.6%$26.62M$94.14M-1.83490Analyst ForecastNegative NewsTMOThermo Fisher Scientific4.8763 of 5 stars$518.80+0.2%$653.23+25.9%-10.8%$195.72B$42.88B31.39130,000Positive News Remove Ads Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ILMN Stock Free ILMN Stock Alerts